This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.
More From The Market Online

Week 24 Wrap: WW3 looms (again); US econ data tepid & silver surfing
By and large, I don't think I'd be without peers when I said the biggest thing…
- Jonathon Davidson
- 3 mins
- 13 June 2025 16:23 (AEST)

HotCopper Highlights, Week 24: Israel boosts Energy; Meeka eyes production & Mag7 back
Good Afternoon and welcome to HotCopper Highlights for Week 24 of the year, I’m Jon Davidson.…
- Jonathon Davidson
- 2 mins
- 13 June 2025 16:32 (AEST)

HotCopper officially kicks off DealRoom, a groundbreaking Capital Raising service
Already Australia’s most popular and most-used finance website, HotCopper has officially kicked off DealRoom: a capital raising service
- Jonathon Davidson
- 2 mins
- 05 June 2025 10:35 (AEST)

Listen: HotCopper Wire Podcast 013 – They changed the IPO rules (and that’s a good thing)
Welcome to this week’s HotCopper Wire, our market watch podcast!
- Isaac McIntyre
- 1 min
- 12 June 2025 16:19 (AEST)